Investor Database
2,357 investors tracked · Peer Scores computed from real founder reviews
Geodesic's third fund..
We invest in the best tech-enabled businesses in the UK, Nordics & Netherlands, leading rounds at Series A/B.
We invest in startups defined by automation and platforms that scale. We aim for 100+ startups per year with established ARR via crowdfunding or co-investment.
We invest in opportunities with near term milestones and clear technology advantages backed by strong teams and IP.
We invest in dual-use and deep tech startups, leveraging Starburst 4x markup and Fortune Global 500 partners.
We invest in B2B software across all industries.
I invest in (personal investment) early stage healthcare start-ups and biotech companies developing unique technologies.
We invest in healthcare and medical startups, including medical technology and digital health, across all stages through multiple funds.
We invest in founders and entrepreneurs looking to grow their business or provide succession planning.
We invest in startups whose technologies have the potential to transform how people experience and achieve financial security, with four key strategic areas of focus: (1) Client experience and deepening engagement, (2) Dynamic underwriting and health data analytics, (3) Expanding distribution capabilities via “AdvisorTech,” and (4) Acquiring the next generation of clients.
We invest in European deeptech companies. We typically invest 3 to 5M€ in 6 to 20M€ round. Deeptech companies (ie – advanced materials, components, systems, software). Strong appetence for B2B business models. Europe. (outside EU only with a strong bias, with smaller tickets).
We invest in early-stage software startups B2C and B2B2C models (and B2B with short sale cycles) Tech-oriented companies, ideally proprietary, with a scalable product We like to be the first professional investor, coming in right after love money and business angels
We invest in tech and tech enabled start ups with a sweet spot for fintech
I invest in Early Revenue Tech and Tech-Enabled start-up
We invest in mid-continent B2B software and technology companies – with $3MM to $10MM in revenue, proven business models, and strong teams – that are ready to scale. The Plymouth team brings decades of experience as operators, advisors, and investors, and understands that while metrics matter, it’s people that are critical to growth.
We invest in FinTech, B2B SaaS, Cybersecurity, EdTech, Future of Work, PropTech, InsurTech, MarTech, LegalTech, Regulatory Tech
We invest in early-stage startups with overlooked founders in humanity-focused sectors (primarily) Fintech, ClimateTech, and future of work/education. We are geographically agnostic. Pre-seed to series A.
Meritech's latest fund..
SHV growth and opportunity investing..
EQT Ventures' third fund..
Advisory and investment firm focusing on cross-border transactions and growth-stage investments in Turkish companies.
We invest in pre-Series A companies (Pre-Seed and Seed). We are NOT thesis-driven in the way most VCs are. Our strategy is to invest in great founders in the earliest days of building a company and to invest broadly across industry, category, theme, trend, etc. Great founders at early stage with big ideas - that's our thesis (if we had to write it out)
We invest in early-stage European companies within the technology and healthcare sectors.
We invest in Robotics, A.I., Deep Tech, Future of Work
We invest in B2B SaaS startups with $1-7M in ARR
We invest in three broad areas: -Energy : clean energy, green projects and international infrastructure projects. -Technology: focus on service companies and internet oriented companies. -Entertainment: royalty lending, movie production and development, financing Software is still eating the world.
We invest in Budding New Writers, Authors & Media Platforms.
We invest in B2B software, SaaS, Construction, HealthTech, Sciences, Agritech, Robotics, Cybersecurity and many others. We invest in startups with sizeable market opportunities in the early stages, which include Seed, Series A, and Series B rounds.
We invest in outside perspectives disrupting overlooked, antiquated and long-standing industries
We invest in early-stage Israel-based/Israeli-led startups developing innovative and technologically advanced solutions, validated by our broad enterprise network.
We invest early in people building innovative and disruptive technologies for human health, the future-of-work, and the infrastructure that powers them both. Our broad investment thesis allows us to see a wide variety of companies, and pick those with the greatest potential for global impact, led by the best founders. We typically write $100K - $2M first checks into pre-Series A rounds, and are comfortable either leading or participating.
We invest in B2B software companies revolutionizing legacy industries. We are sector-agnostic, with a geographic focus on Northeast US major markets. As entrepreneurs ourselves, we focus on GTM acceleration, operational execution, and capital strategy. With our founder-focused DNA, concentrated portfolio, and disciplined investment process, we help entrepreneurs build category-leading companies.
Eurazeo's latest growth fund..
We invest in companies with relevant applications in the built environment, including productivity and climate as the key themes.
We invest in Medtech, e-health, Software, service, CDMO/CRO innovationm, health. Early revenue/growth, non profitable.
We invest in construction, real estate, climate, and logistics.
We invest in creative biosciences - companies building new biology for applications in human health (therapeutics, diagnostics, and devices) and industry (sustainability and synthetic biology). We invest in Seed and Series A companies.
TLcom's third fund..
We invest in emerging and innovative founders achieving positive impact through technology and sustainable business models. As an impact-driven fund we focus on transformative startups from seed to series B stages which fit our three investment themes: climate technology, industry and infrastructure technology, and social impact technology.
Greylock's growth program..
We invest in B2C/ B2B2C Fintech, Insurtech and Digital Health startups who can benefit from NFP's distribution.
Founders Fund's latest vintage..
We invest in the global Internet, hardware and financial technology industries.
We invest in global Series A and B. Minority investments within deeptech, mobility, sustainability, materials and automotive related sectors.
We invest in pre-seed to seed stage, blockchain, crypto, and web3 startups. We seek companies early, under $25M in valuation.
We invest in high-quality management teams building a more environmentally sound, resource-efficient future.
We invest in industrial and life science technology companies.
We invest in daring, internationally-ambitious, European digital entrepreneurs from Day One.
Tiger Global's latest fund..
We invest in ambitious entrepreneurs building products across cloud, connectivity, data science and security with the potential to impact whole industries. That includes AI, machine learning, cloud computing, cybersecurity, HPC, IoT, quantum computing and wireless connectivity / networking to name a few areas.